Friday, January 6, 2017

Nature Medicine Contents: January 2017 Volume 23 Number 1 pp 1-135

If you are unable to see the message below, click here to view.
Nature Medicine


Advertisement
nature.com webcasts

Springer Nature presents a custom webcast on: CRISPR/Cas9 strategies for disease modeling and drug discovery

Date: Tuesday, 24 January 2017
Time: 8AM PST, 11AM EST, 4PM GMT, 5PM CST 

Register for FREE

Sponsored by: 
The Jackson Laboratory
 
TABLE OF CONTENTS

January 2017 Volume 23, Issue 1

Editorial
Correction
News
News and Views
Review
Articles
Letters
Advertisement
Nature Index 2016 Australia & New Zealand

Nature Index 2016 Australia and New Zealand highlights the quality natural science research within these countries. This supplement examines the cities and institutions that largely contribute to the research as well as the factors that drive their success. 

Access the free supplement for six months! 


Subscribe
 
Facebook
 
RSS
 
Recommend to library
 
Twitter
 

Advertisement
nature.com webcasts

Springer Nature presents a custom webcast on: Liquid biopsy: CTC-based classifier predicts chemo resistance in lung cancer

Date: Thursday January 19 2017
Time: 8AM PST, 11AM EST, 4PM GMT, 5PM CET 

Register for FREE 

Sponsored by: 
Menarini Silicon Biosystems
 
 
Advertisement
CRISPR Calendar 2017

To celebrate the continuing rise to fame of the CRISPR system, the Nature Reviews Genetics 2017 CRISPR calendar highlights the underlying biology of CRISPR, as well as its diverse range of exciting potential applications in genetic research, biotechnology and therapeutics.

Download the calendar free online

Produced with support from 
OriGene
 

Advertisement
Environmental Microbial Biofilms and Human Microbiomes: Drivers of Future Sustainability 

February 12-15, 2017 | Nanyang Executive Centre, Singapore


Presented by: Nanyang Technological University (NTU) | Singapore Centre for Environmental Life Sciences Engineering (SCELSE) | npj Biofilms and Microbiomes 

Register now!
 

Editorial

Top

Safeguarding science   p1
doi:10.1038/nm.4270
Changing political and funding landscapes in the US create an uncertain environment for biomedical research. The research community must insist that scientific policy follow from science, not political partisanship.

Correction

Top

Correction   p10
doi:10.1038/nm0117-10

News

Top

Disease in three dimensions: Tissue engineering takes on infectious disease   pp2 - 4
Shraddha Chakradhar
doi:10.1038/nm0117-2

Living therapeutics: Scientists genetically modify bacteria to deliver drugs   pp5 - 7
Amy Maxmen
doi:10.1038/nm0117-5

Alternative analgesics: New drugs for pain seek to improve on ketamine's benefits   pp8 - 10
Carrie Arnold
doi:10.1038/nm0117-8

News and Views

Top

A microbial protein that alleviates metabolic syndrome   pp11 - 12
Fernando Forato Anhe and Andre Marette
doi:10.1038/nm.4261
A recent study shows that pasteurization of Akkermansia muciniphila enhances the bacterium's ability to reduce fat mass and metabolic syndrome in mice with diet-induced obesity, and that Amuc_1100*, a thermostable outer-membrane protein of A. muciniphila, can reproduce these beneficial effects.

See also: Letter by Plovier et al.

A bone marrow factor contributes to kidney disease   pp13 - 14
Stuart J Shankland and J Ashley Jefferson
doi:10.1038/nm.4263
Soluble urokinase plasminogen activator receptor (suPAR) is a circulating biomarker of inflammation. A recent study identifies immature myeloid cells in the bone marrow as a major cellular source of suPAR that contributes to kidney disease.

See also: Letter by Hahm et al.

Starving leukemia to induce differentiation   pp14 - 15
Chia-Wei Cheng and Omer H Yilmaz
doi:10.1038/nm.4259
A new study shows that fasting induces the differentiation and elimination of some types of leukemia in mice, which implicates fasting or its mimetics as a novel strategy for the treatment of this disease.

See also: Article by Lu et al.

Imaging biomarkers and biotypes for depression   pp16 - 17
Tor D Wager and Choong-Wan Woo
doi:10.1038/nm.4264
A new study identifies four distinct 'biotypes' of depression on the basis of fMRI resting-state functional connectivity in a diverse sample of more than 1,000 individuals. The biotypes are diagnostic of depression and predict treatment response.

See also: Article by Drysdale et al.

Nature Medicine
JOBS of the week
Exciting PhD Positions in Molecular Medicine
CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences
Tenure Associate Professor or Full Professor
University of Calgary
Director
University of Pittsburgh
Tenured / Tenure Track Faculty Position in Pediatric Epilepsy
Indiana University School of Medicine
Postdoctoral Fellow (212274)
Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc.
More Science jobs from
Nature Medicine
EVENT
2nd EACR-OECI Conference: Making it Personal: Cancer Precision Medicine
13.03.17
Amsterdam, Netherlands
More science events from

Review

Top

T memory stem cells in health and disease   pp18 - 27
Luca Gattinoni, Daniel E Speiser, Mathias Lichterfeld and Chiara Bonini
doi:10.1038/nm.4241
Gattinoni and colleagues discuss the emerging roles of this subset of long-lived memory T lymphocytes, and highlight ways in which these cells might be exploited to achieve therapeutic aims.

Advertisement
Nature Outlook: Precision Medicine

Health care that is tailored on the basis of an individual's genes, lifestyle or environment, is not a modern concept. But advances in genetics and the growing availability of health data for researchers and physicians promise to make this new era of medicine more personalized than ever before.

Access the Outlook free online

Sponsored by:
Illumina, Inc.
 
 

Articles

Top

Resting-state connectivity biomarkers define neurophysiological subtypes of depression   pp28 - 38
Andrew T Drysdale, Logan Grosenick, Jonathan Downar, Katharine Dunlop, Farrokh Mansouri et al.
doi:10.1038/nm.4246
Using functional MRI in a large multisite sample of more that 1,000 patients, four distinct neurophysiological biotypes of depression are defined. These biotypes are used to develop diagnostic classifiers that distinguish patients with depression from controls in separate multisite validation and replication cohorts, and can predict patient responsiveness to therapy.

See also: News and Views by Wager & Woo

Thalamic miR-338-3p mediates auditory thalamocortical disruption and its late onset in models of 22q11.2 microdeletion   pp39 - 48
Sungkun Chun, Fei Du, Joby J Westmoreland, Seung Baek Han, Yong-Dong Wang et al.
doi:10.1038/nm.4240
The thalamus-enriched microRNA miR-338-3p is depleted in mouse models of 22q11.2 deletion syndrome and in humans with schizophrenia, leading to a late-onset dysfunction of auditory thalamocortical synaptic transmission, behavioral abnormalities and altered sensitivity to antipsychotics.

Engineered human pluripotent-stem-cell-derived intestinal tissues with a functional enteric nervous system   pp49 - 59
Michael J Workman, Maxime M Mahe, Stephen Trisno, Holly M Poling, Carey L Watson et al.
doi:10.1038/nm.4233
Organoids formed by combining pluripotent-stem-cell-derived human neural crest cells with pluripotent-stem-cell-derived intestinal tissue show functional interstitial cells of Cajal and undergo waves of contraction; these tissues reveal insights into the molecular defects characterizing Hirschsprung's disease.

Genome-wide CRISPR screens reveal a Wnt-FZD5 signaling circuit as a druggable vulnerability of RNF43-mutant pancreatic tumors   pp60 - 68
Zachary Steinhart, Zvezdan Pavlovic, Megha Chandrashekhar, Traver Hart, Xiaowei Wang et al.
doi:10.1038/nm.4219
A genome-wide CRISPR screen reveals that FZD5, but none of the other nine Frizzled receptors encoded in the human genome, is a therapeutic vulnerability of pancreatic and colorectal tumors bearing RNF43 mutations.

Loss of the histone methyltransferase EZH2 induces resistance to multiple drugs in acute myeloid leukemia   pp69 - 78
Stefanie Gollner, Thomas Oellerich, Shuchi Agrawal-Singh, Tino Schenk, Hans-Ulrich Klein et al.
doi:10.1038/nm.4247
Proteasomal degradation of EZH2 in AML patients in response to therapy triggers the expression of stem cell markers and has been identified as an epigenetic pathway leading to acquired drug resistance. Treatments aimed to restore EZH2 expression in relapsed AML patients have shown clinical efficacy and constitute a viable approach to re-sensitize tumors to chemotherapy.

Fasting selectively blocks development of acute lymphoblastic leukemia via leptin-receptor upregulation   pp79 - 90
Zhigang Lu, Jingjing Xie, Guojin Wu, Jinhui Shen, Robert Collins et al.
doi:10.1038/nm.4252
In leukemic mice, fasting reduces the development of acute lymphoblastic leukemia, but not acute myeloid leukemia, via upregulation of leptin receptor expression and signaling in the leukemic cells.

See also: News and Views by Cheng & Yilmaz

Dickkopf-1 promotes hematopoietic regeneration via direct and niche-mediated mechanisms   pp91 - 99
Heather A Himburg, Phuong L Doan, Mamle Quarmyne, Xiao Yan, Joshua Sasine et al.
doi:10.1038/nm.4251
The Wnt pathway inhibitor Dkk1, which is produced by bone marrow osteolineage cells, promotes hematopoietic recovery after radiation injury by both direct effects on hematopoietic cells and indirect effects on bone marrow endothelial cells.

Advertisement
January 2017 marks the 1st anniversary of Nature Microbiology! Visit the journal to see what’s been publishing and submit your research.

Interested in our forum to discuss and share opinions about microbiology? Join the Nature Microbiology Community!

 

Letters

Top

Bone marrow-derived immature myeloid cells are a main source of circulating suPAR contributing to proteinuric kidney disease   pp100 - 106
Eunsil Hahm, Changli Wei, Isabel Fernandez, Jing Li, Nicholas J Tardi et al.
doi:10.1038/nm.4242
Soluble uPAR is known to contribute to certain types of chronic kidney disease, and myeloid cells from the bone marrow have now been shown to be a key source of this factor.

See also: News and Views by Shankland & Jefferson

A purified membrane protein from Akkermansia muciniphila or the pasteurized bacterium improves metabolism in obese and diabetic mice   pp107 - 113
Hubert Plovier, Amandine Everard, Celine Druart, Clara Depommier, Matthias Van Hul et al.
doi:10.1038/nm.4236
Akkermansia muciniphila, a member of the gut microbiome, has been shown to improve metabolism in mice. Here it is reported that its pasteurization further improves this effect, and that one of its membrane proteins by itself has a similar benefit.

See also: News and Views by Anhe & Marette

Molecular analysis of circulating tumor cells identifies distinct copy-number profiles in patients with chemosensitive and chemorefractory small-cell lung cancer   pp114 - 119
Louise Carter, Dominic G Rothwell, Barbara Mesquita, Christopher Smowton, Hui Sun Leong et al.
doi:10.1038/nm.4239
Copy-number alterations detected in circulating tumor cells at time of diagnosis predict chemosensitive versus chemorefractory responses; however, CTCs obtained after subsequent relapse bear a chemosensitive copy-number alteration profile, which suggests that different mechanisms drive initial and acquired chemoresistance.

Systemic depletion of L-cyst(e)ine with cyst(e)inase increases reactive oxygen species and suppresses tumor growth   pp120 - 127
Shira L Cramer, Achinto Saha, Jinyun Liu, Surendar Tadi, Stefano Tiziani et al.
doi:10.1038/nm.4232
By reducing the availability of extracellular L-cyst(e)ine, an engineered enzyme inhibits glutathione production and cripples antioxidant defenses of tumors in a variety of mouse models.

Interleukin-33-induced expression of PIBF1 by decidual B cells protects against preterm labor   pp128 - 135
Bihui Huang, Azure N Faucette, Michael D Pawlitz, Bo Pei, Joshua W Goyert et al.
doi:10.1038/nm.4244
B cells protect against inflammation-associated preterm labor via IL-33-induced PIBF1 expression in mice, which suggests a therapy for this condition in humans.

Top
Advertisement
All content now free to access including archives!

Nature Communications is an open access journal that publishes high-quality research from all areas of the natural sciences. Papers published by the journal represent important advances of significance to specialists within each subject area including the life sciences.

Visit the website to explore ALL the content available within your field.
 
nature events
Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here.
Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com
More Nature Events

You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/myaccount
(You will need to log in to be recognised as a nature.com registrant)

For further technical assistance, please contact our registration department

For print subscription enquiries, please contact our subscription department

For other enquiries, please contact our customer feedback department

Nature Publishing Group | One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA

Nature Publishing Group's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston

Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW.

© 2017 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.

nature publishing group

No comments: